Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: A study of the International Myeloma Working Group

J. Hillengass, L. A. Moulopoulos, S. Delorme, V. Koutoulidis, J. Mosebach, T. Hielscher, Matthew M Drake, S Vincent Rajkumar, B. Oestergaard, N. Abildgaard, M. Hinge, T. Plesner, Y. Suehara, K. Matsue, N. Withofs, J. Caers, A. Waage, H. Goldschmidt, M. A. Dimopoulos, S. LentzschB. Durie, E. Terpos

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

For decades, conventional skeletal survey (CSS) has been the standard imaging technique for multiple myeloma (MM). However, recently whole-body computed tomography (WBCT) has been implemented into the diagnostic criteria of MM. This analysis compares sensitivity and prognostic significance of WBCT and CSS in patients with smoldering MM (SMM) and MM. Fifty-four of 212 patients (25.5%) had a negative CSS and a positive WBCT for osteolytic lesions (P<0.0001). Of 66 patients with SMM based on CSS, 12 (22.2%) had osteolytic lesions on WBCT. In comparison, WBCT failed to detect some bone destructions in the appendicular skeleton possibly due to limitations of the field of view. Presence of lytic bone lesions in WBCT was of borderline prognostic significance (P=0.051) for SMM patients, with a median time to progression of 38 versus 82 months for those without bone destructions. In conclusion, WBCT identifies significantly more sites of bone destruction than CSS. More than 20% of patients with SMM according to CSS have in fact active MM detectable with WBCT. On the basis of this and other studies, WBCT (either computed tomography (CT) alone or as part of a positron emission tomography-CT protocol) should be considered the current standard for the detection of osteolytic lesions in MM.

Original languageEnglish (US)
Article numbere599
JournalBlood Cancer Journal
Volume7
Issue number8
DOIs
StatePublished - Aug 25 2017

Fingerprint

Multiple Myeloma
Tomography
Bone and Bones
Surveys and Questionnaires
Skeleton

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma : A study of the International Myeloma Working Group. / Hillengass, J.; Moulopoulos, L. A.; Delorme, S.; Koutoulidis, V.; Mosebach, J.; Hielscher, T.; Drake, Matthew M; Rajkumar, S Vincent; Oestergaard, B.; Abildgaard, N.; Hinge, M.; Plesner, T.; Suehara, Y.; Matsue, K.; Withofs, N.; Caers, J.; Waage, A.; Goldschmidt, H.; Dimopoulos, M. A.; Lentzsch, S.; Durie, B.; Terpos, E.

In: Blood Cancer Journal, Vol. 7, No. 8, e599, 25.08.2017.

Research output: Contribution to journalArticle

Hillengass, J, Moulopoulos, LA, Delorme, S, Koutoulidis, V, Mosebach, J, Hielscher, T, Drake, MM, Rajkumar, SV, Oestergaard, B, Abildgaard, N, Hinge, M, Plesner, T, Suehara, Y, Matsue, K, Withofs, N, Caers, J, Waage, A, Goldschmidt, H, Dimopoulos, MA, Lentzsch, S, Durie, B & Terpos, E 2017, 'Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: A study of the International Myeloma Working Group', Blood Cancer Journal, vol. 7, no. 8, e599. https://doi.org/10.1038/bcj.2017.78
Hillengass, J. ; Moulopoulos, L. A. ; Delorme, S. ; Koutoulidis, V. ; Mosebach, J. ; Hielscher, T. ; Drake, Matthew M ; Rajkumar, S Vincent ; Oestergaard, B. ; Abildgaard, N. ; Hinge, M. ; Plesner, T. ; Suehara, Y. ; Matsue, K. ; Withofs, N. ; Caers, J. ; Waage, A. ; Goldschmidt, H. ; Dimopoulos, M. A. ; Lentzsch, S. ; Durie, B. ; Terpos, E. / Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma : A study of the International Myeloma Working Group. In: Blood Cancer Journal. 2017 ; Vol. 7, No. 8.
@article{0aa6f691168246c58277778101d12033,
title = "Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: A study of the International Myeloma Working Group",
abstract = "For decades, conventional skeletal survey (CSS) has been the standard imaging technique for multiple myeloma (MM). However, recently whole-body computed tomography (WBCT) has been implemented into the diagnostic criteria of MM. This analysis compares sensitivity and prognostic significance of WBCT and CSS in patients with smoldering MM (SMM) and MM. Fifty-four of 212 patients (25.5{\%}) had a negative CSS and a positive WBCT for osteolytic lesions (P<0.0001). Of 66 patients with SMM based on CSS, 12 (22.2{\%}) had osteolytic lesions on WBCT. In comparison, WBCT failed to detect some bone destructions in the appendicular skeleton possibly due to limitations of the field of view. Presence of lytic bone lesions in WBCT was of borderline prognostic significance (P=0.051) for SMM patients, with a median time to progression of 38 versus 82 months for those without bone destructions. In conclusion, WBCT identifies significantly more sites of bone destruction than CSS. More than 20{\%} of patients with SMM according to CSS have in fact active MM detectable with WBCT. On the basis of this and other studies, WBCT (either computed tomography (CT) alone or as part of a positron emission tomography-CT protocol) should be considered the current standard for the detection of osteolytic lesions in MM.",
author = "J. Hillengass and Moulopoulos, {L. A.} and S. Delorme and V. Koutoulidis and J. Mosebach and T. Hielscher and Drake, {Matthew M} and Rajkumar, {S Vincent} and B. Oestergaard and N. Abildgaard and M. Hinge and T. Plesner and Y. Suehara and K. Matsue and N. Withofs and J. Caers and A. Waage and H. Goldschmidt and Dimopoulos, {M. A.} and S. Lentzsch and B. Durie and E. Terpos",
year = "2017",
month = "8",
day = "25",
doi = "10.1038/bcj.2017.78",
language = "English (US)",
volume = "7",
journal = "Blood Cancer Journal",
issn = "2044-5385",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma

T2 - A study of the International Myeloma Working Group

AU - Hillengass, J.

AU - Moulopoulos, L. A.

AU - Delorme, S.

AU - Koutoulidis, V.

AU - Mosebach, J.

AU - Hielscher, T.

AU - Drake, Matthew M

AU - Rajkumar, S Vincent

AU - Oestergaard, B.

AU - Abildgaard, N.

AU - Hinge, M.

AU - Plesner, T.

AU - Suehara, Y.

AU - Matsue, K.

AU - Withofs, N.

AU - Caers, J.

AU - Waage, A.

AU - Goldschmidt, H.

AU - Dimopoulos, M. A.

AU - Lentzsch, S.

AU - Durie, B.

AU - Terpos, E.

PY - 2017/8/25

Y1 - 2017/8/25

N2 - For decades, conventional skeletal survey (CSS) has been the standard imaging technique for multiple myeloma (MM). However, recently whole-body computed tomography (WBCT) has been implemented into the diagnostic criteria of MM. This analysis compares sensitivity and prognostic significance of WBCT and CSS in patients with smoldering MM (SMM) and MM. Fifty-four of 212 patients (25.5%) had a negative CSS and a positive WBCT for osteolytic lesions (P<0.0001). Of 66 patients with SMM based on CSS, 12 (22.2%) had osteolytic lesions on WBCT. In comparison, WBCT failed to detect some bone destructions in the appendicular skeleton possibly due to limitations of the field of view. Presence of lytic bone lesions in WBCT was of borderline prognostic significance (P=0.051) for SMM patients, with a median time to progression of 38 versus 82 months for those without bone destructions. In conclusion, WBCT identifies significantly more sites of bone destruction than CSS. More than 20% of patients with SMM according to CSS have in fact active MM detectable with WBCT. On the basis of this and other studies, WBCT (either computed tomography (CT) alone or as part of a positron emission tomography-CT protocol) should be considered the current standard for the detection of osteolytic lesions in MM.

AB - For decades, conventional skeletal survey (CSS) has been the standard imaging technique for multiple myeloma (MM). However, recently whole-body computed tomography (WBCT) has been implemented into the diagnostic criteria of MM. This analysis compares sensitivity and prognostic significance of WBCT and CSS in patients with smoldering MM (SMM) and MM. Fifty-four of 212 patients (25.5%) had a negative CSS and a positive WBCT for osteolytic lesions (P<0.0001). Of 66 patients with SMM based on CSS, 12 (22.2%) had osteolytic lesions on WBCT. In comparison, WBCT failed to detect some bone destructions in the appendicular skeleton possibly due to limitations of the field of view. Presence of lytic bone lesions in WBCT was of borderline prognostic significance (P=0.051) for SMM patients, with a median time to progression of 38 versus 82 months for those without bone destructions. In conclusion, WBCT identifies significantly more sites of bone destruction than CSS. More than 20% of patients with SMM according to CSS have in fact active MM detectable with WBCT. On the basis of this and other studies, WBCT (either computed tomography (CT) alone or as part of a positron emission tomography-CT protocol) should be considered the current standard for the detection of osteolytic lesions in MM.

UR - http://www.scopus.com/inward/record.url?scp=85028568435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028568435&partnerID=8YFLogxK

U2 - 10.1038/bcj.2017.78

DO - 10.1038/bcj.2017.78

M3 - Article

C2 - 28841211

AN - SCOPUS:85028568435

VL - 7

JO - Blood Cancer Journal

JF - Blood Cancer Journal

SN - 2044-5385

IS - 8

M1 - e599

ER -